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PERKEMBANGAN KAEDAH ANALITIKAL BAHARU UNTUK 
MEMPROFIL STEROID BAGI KEGUNAAN DOPING 
ABSTRAK 
Sebatian profil steroid iaitu testosteron (T), epitestosteron (E), androsteron 
(A), etiocholanolon (Etio), 5alpha-androstan-3alpha, 17beta-diol (5αAdiol), 5beta-
androstan-3alpha, 17beta-diol (5βAdiol) dan nisbah T kepada E (T/E) telah 
ditentukan di dalam urin sukarelawan lelaki yang mengambil makanan tambahan 
Tongkat Ali (TA) menggunakan pengekstrakan fasa pepejal (SPE) dan fasa cecair 
cecair (LLE). Daripada 47 sampel, 11 sampel telah melanggar garis panduan World 
Anti-Doping Agency (WADA) dan kaedah pengesahan yang menggunakan gas 
kromatografi pembakaran nisbah isotop spektrometri jisim (GC-C-IRMS) 
menunjukkan 5 sampel adalah konsisten dengan punca eksogen (Δδ13C > 3‰). Dua
kaedah pengekstrakan mikro iaitu pengekstrakan mikro cecair-cecair berbantukan 
vorteks (VALLME) dan pengekstrakan mikro fasa pepejal (μ-SPE) menggunakan 
LC-MS/MS telah dibangunkan. Turus Emas Hypersil (50 mm × 2.1 mm, 1.9 μm) 
dengan elusi cerunan menghasilkan pemisahan dasar untuk kesemua sebatian dalam 
masa 8 min. Ion yang dipantau adalah m/z 289.4> 97.3 untuk T dan E, 273.4> 255.3 
untuk A dan Etio dan 275.4> 257.3 untuk 5αAdiol dan 5βAdiol menggunakan 
pengionan penyembur elektron dalam mod kekutuban positif. Keadaan 
pengekstrakan optimum untuk sampel 5 mL dalam VALLME adalah: pelarut  estrak, 
1-pentanol; isipadu pelarut, 150 μL; masa vorteks, 40 s; kelajuan dan masa emparan,
1000 rpm selama 1 min tanpa penambahan garam yang diperlukan dalam 
pengekstrakan. Keadaan  pengekstrakan optimum untuk sampel 3 mL dalam μ-SPE 
ialah: pelarut estrak, asetonitril; isipadu pelarut, 300 μL; masa pengekstrakan, 30 min 
xx
dan masa penyerapan, 20 min untuk mengekstrak. Kaedah VALLME-LC-MS/MS 
dan μ-SPE-LC-MS/MS memenuhi syarat WADA dari segi kepekaan, had 
pengesanan, kebolehulangan, kelinearan dan lasak. Tambahan pula, teknik alternatif 
ini adalah mudah, pantas dan mesra alam dengan pengurangan jumlah pelarut yang 
ketara. 
xxi
DEVELOPMENT OF NEW ANALYTICAL METHODS FOR STEROID 
PROFILING FOR DOPING PURPOSES 
ABSTRACT 
The steroid profile compounds namely testosterone (T), epitestosterone (E), 
androsterone (A), etiocholanolone (Etio), 5alpha-androstane-3alpha,17beta-diol 
(5αAdiol), 5beta-androstane-3alpha,17beta-diol (5βAdiol) and the ratio of T to E 
(T/E)) has been  determined in urine of male volunteers who consumed Tongkat Ali 
(TA) supplement using the solid phase extraction (SPE) and liquid-liquid extraction 
(LLE) method. From 47 samples, 11 samples violated the World Anti-Doping 
Agency (WADA) guidelines and confirmation by gas chromatography combustion 
isotope ratio mass spectrometry (GC-C-IRMS) showed 5 samples were consistent 
with the exogenous origin (Δδ13C > 3‰). Two microextraction methods, i.e., vortex-
assisted liquid-liquid microextraction (VALLME) and micro-solid phase extraction 
(µ-SPE) followed by LC-MS/MS were developed. Hypersil Gold C18 column (50 
mm × 2.1 mm, 1.9 µm) with gradient elution resulted in baseline separation for 
compounds in about 8 min. The monitored ions are m/z 289.4 > 97.3 for T and E, 
m/z 273.4 > 255.3 for A and Etio and m/z 275.4 > 257.3 for  5αAdiol and 5βAdiol 
using electron spray ionization in the positive polarity mode. The optimum extraction 
conditions for 5 mL sample using the VALLME were: extraction solvent, 1-
pentanol; volume of extractant, 150 µL; vortex time, 40 s; centrifuge speed and time, 
1000 rpm for 1 min with no salt addition needed for the extraction. The optimum 
extraction conditions for 3 mL sample using the µ-SPE were: extraction solvent, 
acetonitrile; volume of extractant, 300 µL; extraction time, 30 min and desorption 
time, 20 min for the extraction. The VALLME-LC-MS/MS and µ-SPE-LC-MS/MS 
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methods meet WADA requirements in terms of sensitivity, limit of detection, 
reproducibility, linearity and robustness.  Furthermore, these alternative techniques 
were simple, rapid and environmentally friendly as markedly reduced amounts of 
solvents were involved.   
1 
CHAPTER ONE 
INTRODUCTION 
1.1 Background 
The use of performance-enhancing drugs or doping by professional athletes 
has been acknowledged as a serious problem since the 1960s. Doping is defined as 
the use of drugs or other substances for performance enhancement. It has become an 
important topic in virtually every sport (Claudia & Shane, 2014) and has been 
discovered in athletes of all ages and at every level of competition (Catlin and 
Thomas, 1996). The use of performance-enhancing drugs is prohibited in sports. 
Athletes who are found to have used such banned substances, either through positive 
drugs test or the athlete biological passport (ABP) system, will be banned for 
competition for a length of time which reflects the severity of the infraction. 
The anabolic androgenic steroids (AAS) are a family of hormones that 
includes the natural male hormone testosterone (T), together with numerous closely 
related chemical derivatives (Kanayama et al., 2010). All AAS possess both anabolic 
(muscle-building) and androgenic (masculine) properties, and they affect a wide 
range of physiological systems. The changing trends in steroid abuse have only been 
preceded by the rapidly advancing analytical technologies that can cover a wider 
range of compounds and achieve lower limits of detection (Scarth et al., 2012). 
According to the regulations of the World Anti-Doping Agency (WADA), AAS are 
classified as prohibited substances in sports (WADA Prohibited List 2017) as 
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summarized in Table 1.1. This table shows that AAS are covered under section “S1. 
Anabolic Agents, 1. Anabolic Androgenic Steroids (AAS)” are further subdivided 
into “a. Exogenous AAS” refers to a substance which is not ordinarily produced by 
the body and “b. Endogenous AAS (EAAS)” refers to a substance which ordinarily is 
produced by the body naturally.  
 
1.2 Doping Cases in Sports 
 
The fight against doping is a top priority for the International Olympic 
Committee (IOC), which has established a zero-tolerance policy to combat cheating 
and to punish anyone responsible for using or providing doping products. The IOC’s 
fight against doping began in earnest in the 1960s (IOC Factsheet, 2016). It is 
currently carried out in close cooperation with WADA which was created in 1999 in 
Lausanne under the initiative of the IOC and with the support and participation of 
inter-governmental organisations, governments, administrators and other public and 
private bodies involved in the fight against doping in sports (Dionne, 2005). Table 
1.2 summarises  doping cases carried out during the Olympic games since 1968. 
Overall, the percentage of doping cases reported was less than 1%.  Athens 2004 was 
the most doped Olympics with 26 reported violations of anti-doping rules. 
Weightlifting is the most doped sport with 36 violations that represent 28.4% of all 
Olympic doping cases (Stefania and Filomena, 2014). Doping is the most serious 
threat to elite sports because it harms athletes’ health, decrease equal opportunities 
for athletes and leads to unfair games (David et al., 2007). 
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Table 1.1: WADA Prohibited List 2017 
SUBSTANCES & METHODS PROHIBITED AT ALL TIMES  
(IN- AND OUT-OF-COMPETITION) 
PROHIBITED SUBSTANCE 
S0 NON-APPROVED SUBSTANCES 
Any pharmacological substance which is not addressed by any of the subsequent sections of the List 
and with no current approval by any governmental regulatory health authority for human therapeutic 
use (e.g. drugs under pre-clinical or clinical development or discontinued, designer drugs, substances 
approved only for veterinary use) is prohibited at all times. 
 
S1 ANABOLIC AGENTS  
Anabolic agents are prohibited. 
     1. ANABOLIC ANDROGENIC STEROIDS (AAS)  
         a. Exogenous AAS 
         b. Endogenous AAS when administered exogenously 
    2. OTHER ANABOLIC AGENTS 
“exogenous” refers to a substance which is not ordinarily produced by the body naturally. 
“endogenous” refers to a substance which is ordinarily produced by the body naturally. 
 
S2 PEPTIDE HORMONES, GROWTH FACTORS, RELATED SUBSTANCES, AND 
MIMETICS  
The substances and other substances with similar chemical structure or similar biological effect(s), 
are prohibited. 
 
S3 BETA-2 AGONISTS  
All selective and non-selective beta-2 agonists, including all optical isomers, are prohibited. 
 
S4 HORMONE AND METABOLIC MODULATORS 
 
S5 DIURETICS AND MASKING AGENTS 
 
P2 BETA-BLOCKERS  
 
PROHIBITED METHOD 
M1 MANIPULATION OF BLOOD AND BLOOD COMPONENTS 
 
M2 CHEMICAL AND PHYSICAL MANIPULATION 
 
M3 GENE DOPING  
 
SUBSTANCES & METHODS PROHIBITED IN-COMPETITION 
S6 STIMULANTS  
All stimulants, including all optical isomers, e.g. d- and l- where relevant, are prohibited. 
 
S7 NARCOTICS 
 
S8 CANNABINOIDS 
 
S9 GLUCOCORTICOIDS  
All glucocorticoids are prohibited when administered by oral, intravenous, intramuscular, or rectal 
routes. 
 
P1 ALCOHOL 
Detection will be conducted by analysis of breath and/or blood. The doping violation threshold is 
equivalent to a blood alcohol concentration of 0.10 g L
-1
. 
 
Source: WADA Prohibited List 2017 
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Table 1.2: Summer Olympics Doping Cases 
Year Place No of Test 
No of Doping 
Cases Reported 
% of Doping 
Cases 
Reported 
2012 London, England 5,051 9 0.18 
2008 Beijing, China 4,770 25 0.52 
2004 Athens, Greece 3,667 26 0.71 
2000 Sydney, Australia 2,359 11 0.47 
1996 Atlanta, USA 1,923 2 0.10 
1992 Barcelona, Spain 1,848 5 0.27 
1988 Seoul, S. Korea 1,598 10 0.63 
1984 Los Angeles, USA 1,507 12 0.80 
1980 Moscow, Russia 645 0 0.00 
1976 Montreal, Canada 2,054 11 0.54 
1972 Munich, Germany 2,079 7 0.34 
1968 Mexico City, Mexico 667 1 0.15 
TOTAL 26,900 119 0.44 
Source: IOC Factsheet – The fight against doping and promotion of athletes’ health Update - 
January 2014 (The fight against doping and promotion of athletes’ health / 21 January 2014) 
 
Malaysia is also not free from doping cases. Many Malaysian athletes 
including elite athletes have been detected for doping violations. Among the well-
known athletes involved in doping was Datuk Lee Chong Wei from badminton. He 
was sanctioned for using dexamethasone, a corticosteroid drug. This drug is usually 
used for allergic or inflammatory treatment. He was banned for 8 months until 2015 
from any competition (Channel NewsAsia, 2015). Another elite athlete that was 
involved with a doping case was Sazali Samad from bodybuilding. The prohibited 
substance detected was steroids and he had been banned for 4 years until 2019 from 
any competition (FMT News, 2015). In 2016, a total of 16 athletes in Malaysia have 
been found positive for prohibited substances including sibutramine, diuretics and 
steroids (New Straits Time, 2017). Whatever reason the athletes have given, athletes 
need to be very cautious and take responsibility in what they are consuming, 
especially supplements because in some cases, the manufacturers do not provide any 
details of banned substance in their products. So, athletes should avoid taking 
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supplements unless under the supervision of qualified and knowledgeable doctors 
because of the associated risk of being adulterated with banned substances.  
 
1.3 Endogenous Anabolic Androgenic Steroid (EAAS)  
 
EAAS is a group of natural compounds that are chemically similar to T and 
share the same androgenic action. Administration of these substances for 
enhancement of athletic performance is forbidden in sports. The administration of 
EAAS that are capable of being physiologically produced by the human body is also 
prohibited in sports (Amy, 2010). As these compounds and their metabolites also 
occur naturally in the human body, specific methods for the detection of the 
exogenous administration of these steroids are required (Ghigo, 2011). For screening 
purposes, urinary concentrations of several endogenous steroids or metabolites is 
generally determined by the GC–MS method (Parr et al., 2011)  
 
The method of steroid profiling (T/E ratio) was introduced into routine 
doping control by Donike et al. (1993). The ratios of these steroids have been proven 
to be very stable (Kerkhof et al., 2000; Donike et al., 1993). The administration of 
steroids such as T, its precursors are proven to alter one or more parameters of the 
urinary steroid profile (Kerkhof et al., 2000). The latest effective date for EAAS 
WADA Technical Document (TD) is TD2016EAAS. The purpose of this TD is to 
harmonize the approaches to the measurement and reporting of EAAS in urine, 
including data in support of the steroidal module of the ABP or “steroid profile”.  
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AAS are chemical compounds capable of enhancing the anabolic processes 
in humans. They affect protein metabolism by stimulating protein synthesis (anabolic 
effect) and inhibiting protein breakdown (anticatabolic effect) (Rooyackers and Nair, 
1997). The group of AAS includes the endogenously produced T, 
dihydrotestosterone (DHT), T prohormones and their metabolites as well as 
exogenous AAS, which are synthetic derivatives of T. T is the primary male sex 
hormone, is both an anabolic and androgenic steroid. It is synthesized from 
cholesterol in the Leydig cells of the testes (Eacker et al., 2008). Small amounts of T 
are also secreted from the ovary and the adrenal gland. DHT is an active metabolite 
of T and a potent androgen in some tissues. Dehydroepiandrosterone (DHEA), 
androstenedione and androstenediol are steroids in the sex hormone biosynthesis 
pathway and are precursors in the endogenous production of T and estrogens 
(Michael, 2002). These steroid precursors are weak androgens secreted primarily by 
the adrenal glands in both sexes. They provide a pool of circulating steroids that can 
be converted to active androgens and estrogens in the peripheral tissues (Michael, 
2002). Anabolic agents were  found to be the highest performance enhancing drug 
(50%) responsible for the Adverse Analytical Findings (AAFs) as may be referred to 
the 2015 Anti-doping test findings from WADA laboratory report (Table 1.3). 
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Table 1.3: Summary of Substances Identified as Adverse Analytical Findings 
(AAFs) in Each Drug Class in Anti-Doping Administration & Management 
System (ADAMS) for All Sports in 2014 
 
Substance Group Occurrences 
% of all ADAMS 
reported findings 
S1. Anabolic Agents  1728 50% 
S6. Stimulants  528 15% 
S5. Diuretics and Other Masking Agents  428 12% 
S9. Glucocorticosteroids  215 6% 
S4. Hormone and Metabolic Modulators  152 4% 
S8. Cannabinoids  127 4% 
S3. Beta-2 Agonists  115 3% 
S2. Peptide Hormones, Growth Factors   
       and Related Substances  
98 3% 
S7. Narcotics 21 1% 
P2. Beta-Blockers  19 1% 
M2. Chemical and Physical Manipulation  1 0.03% 
P1. Alcohol  0 0% 
M1. Enhancement of Oxygen Transfer  0 0% 
TOTAL  3432  
Source: 2015 Anti-Doping Test Findings – Laboratory Report by WADA 
 
Steroid profiling is one of the most versatile and informative screening tools 
for the detection of steroid abuse in sports drug testing. The “steroid profile” in the 
WADA technical document is composed of T, epitestosterone (E), androsterone (A), 
etiocholanolone (Etio), 5alpha-androstane-3alpha,17beta-diol (5αAdiol), 5beta-
androstane-3alpha,17beta-diol (5βAdiol) and the ratio of  T to E (T/E) (Table 1.4). 
These are measured as free steroid content obtained from the free steroid fraction 
plus those released from the conjugated fraction following hydrolysis by 
glucuronidase enzymes.  Other urinary steroids or ratios of steroid metabolites that 
could be useful in evaluating a steroid profile are A/T, A/Etio, 5αAdiol/5βAdiol and 
5αAdiol/E). The confirmation criteria by WADA for steroid profile has been 
summarised in Table 1.5 (WADA TD2016EAAS). Any results above the criteria 
were categorised as “Suspicious Steroid Profile”. 
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Table 1.4: Steroid profile compounds 
No Name and Acronym Structure 
Mol Formula/ 
Mol Weight (Da) 
Log P 
1 
Testosterone 
(T) 
 
C19H28O2 
288.424 
3.34 
2 
Epitestosterone 
(E) 
 
C19H28O2 
288.424 
 
3.37 
3 
Androsterone 
(A) 
 
C19H30O2 
290.440 
 
 
3.77 
4 
Etiocholanolone 
(Etio) 
 
C19H30O2 
290.440 
 
3.75 
5 
5alpha-androstane-
3alpha,17beta-diol 
(5αAdiol) 
 
C19H32O2 
292.456 
 
4.33 
6 
5beta-androstane-
3alpha,17beta-diol 
(5βAdiol) 
 
C19H32O2 
292.456 
 
3.20 
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Table 1.5: WADA confirmation criteria for steroid profile compounds 
Compounds Maximum Allowance by WADA* 
Testosterone (T) 200 ng mL
-1
 in males or 
50 ng mL
-1
 in females Epitestosterone (E) 
Androsterone (A) 10000 ng mL
-1
 combined with A/Etio 
ratio <0.4 in males or > 4.0 in females Etiocholanolone (Etio) 
5αAdiol 250 ng mL-1 
5βAdiol - 
Ratio T to E (T/E) < 4.0 
Source: WADA TD2016EAAS - Endogenous Anabolic Androgenic Steroids 
Measurement and Reporting 
 
1.4 Green Chemistry 
 
Green chemistry is the design of chemical products and processes that 
reduce or eliminate the use or generation of hazardous substances. Green chemistry 
applies across the life cycle of a chemical product, including its design, manufacture, 
use, and ultimate disposal. Green chemistry is also known as sustainable chemistry 
(USEPA, 2017). So, in developing a method, a sustainable development or green 
analytical chemistry should be considered to ensure sustainability for tomorrow. 
Usually, the goal of green analytical chemistry is to use analytical procedures that 
generate less hazardous waste and that are safer to use and more benign to the 
environment (Keith et al., 2007). It is well known that in analytical chemistry most 
methods employ solvents that can harm the environment in terms of its toxicity and 
the volume used. So, new sustainable analytical methods are proposed that 
incorporate procedures that either use less hazardous chemicals or use lesser amounts 
of hazardous chemicals.  
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An important part of the green chemistry philosophy is the need to develop 
and adopt green analytical techniques and procedures. Analytical chemistry takes a 
special place in the green chemistry concept. It is aimed to detect and quantitatively 
determine various substances by means of methods which often use harmful 
reagents. As a result, the analysis itself may become a source of pollution. Analytical 
chemistry is considered to be a small-scale activity, but this is not always true in the 
case of controlling and monitoring laboratories such as anti-doping laboratories 
where a large number of analyses are performed. The use of instrumental methods 
instead of wet chemistry; the miniaturization and automation are the new trends of 
analytical chemistry, making this branch of chemistry more sustainable (Koel and 
Mihkel, 2006). The determination of a broad spectrum of analytes at low 
concentrations (ppb, even ppt) in samples of complex matrix composition has been 
facilitated by the introduction of a new generation of highly sensitive analytical 
devices and by the development of new sample preparation procedures. The 
principles of green chemistry are shown in Figure 1.1. 
 
Most efforts in making chemical processes greener emphasize the need for 
using safer, less toxic, and more benign solvents, or the elimination of solvents 
completely, and reducing   the use of reagents and auxiliaries. Other strategies 
include lower energy consumption through the use of milder reaction conditions 
(Rummi, 2017), avoiding derivatization and a preference for substrates based on 
renewable sources (Marek et al., 2015). In order to improve economic atom, highly 
selective catalytic processes should be performed instead of using additional 
substrates.  
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Figure 1.1: The principles of green chemistry (Anastas and Warner, 1998). 
 
Analytical method needs solvents, reagents, energy, and it creates waste. 
The principles of green analytical chemistry in design of new methods includes  
prevention of waste (Principle 1); safer solvents and auxiliaries (Principle 5); design 
for energy efficiency (Principle 6); avoid chemical derivatives (Principle 8) and safer 
chemistry to minimize the potential of chemical accidents (Principle 12) (Agnieszka 
et al., 2013). The main goal is to avoid or reduce the undesirable environmental side 
effects of chemical analysis, while preserving the classic analytical parameters of 
accuracy, sensitivity, selectivity, and precision. 
 
1.5 Sample Preparation and Analytical Method 
 
The techniques of dope testing have improved immensely from 1972 to 
2017 using improved extraction methods (Reddy et al., 2007) and sophisticated 
equipments (Thevis and Schanzer, 2005). Lower detection limits and better 
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selectivity could also be achieved with improved sample clean-up strategies in order 
to eliminate interferences due to the urine matrix. This approach is generally used 
especially in confirmatory and quantitative analysis since the procedures are often 
compound- or group-specific. Both isolation of analytes from the matrix and their 
pre-concentration are important aspects of this process. Also, it is necessary to clean 
up samples of difficult matrices.  
 
Classical sample pre-treatment techniques (e.g., liquid-liquid extraction 
(LLE) and solid-phase extraction (SPE)) are slow and labour intensive (Gyorgy and 
Karoly, 2004). Often extensive amounts of hazardous organic solvents are used and 
sample volumes can be greater than 1 L. The main disadvantage of LLE in ultra-trace 
analysis is the necessity of using large amounts of very clean solvents and their 
subsequent evaporation is an inevitable step in obtaining significant pre-
concentration. Thus, this technique is both expensive and environmentally unfriendly 
(Kozlowska, et al., 2003). SPE seems to be better, as smaller amounts of organic 
solvents are usually used. However, SPE cartridges are used once only in ultra-trace 
analysis; it is expensive and it also generates larger amount of waste. After use, SPE 
cartridges are disposed by sending to dumping grounds or, in certain cases, waste 
incineration plants. Both these methods are not environmentally friendly (Agnieska  
and Tomasz, 2011). 
 
Immunoaffinity chromatography has been utilized to clean up urine samples 
for GC-MS and High Resolution Mass Spectromtry (HRMS) analysis of metabolites 
of stanozolol and nandrolone (Wu et al., 2012). Liquid Chromatography (LC) 
fractionation has been employed as an additional sample purification step in GC-
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HRMS analysis of methandienone metabolites and GC tandem mass spectrometry 
(GC-MS/MS) and GC-MS analysis of metabolites of stanozolol, nandrolone, 
methyltestosterone and methandienone (Thevis et al., 2013). LLE with n-pentane and 
SPE with amino columns have been reported to clearly improve the quality of 
chromatographic signals and mass spectra in GC-MS analysis of non-polar steroids 
(Moon et al., 2011).  
 
Several microextraction techniques have gained their place in modern 
analytical laboratories. The first solid-phase microextraction (SPME) was introduced 
by Arthur and Pawliszyn (1990). Since then, several other microextraction 
techniques have been developed such as the single-drop microextraction (SDME) 
(Jeannot and Cantwell, 1996; Liu and Dasgupta, 1996) and hollow-fiber liquid-phase 
microextraction (HF-LPME) (Pedersen and Rasmussen, 2008). Basically, 
microextraction offers many advantages over traditional extraction methods. Pre-
concentration of analytes is normally high, sample clean-up is efficient and the 
number of separate stages in sample preparation is minimal (Pedersen and 
Rasmussen, 2008). However, LPME has not been applied to sample preparation of 
unconjugated AAS in urine as routine analysis. 
 
In 2006, the dispersive liquid-liquid microextraction (DLLME) was 
introduced. However, the use of dispersive solvents may decrease the partitioning 
and the mass transfer of the analytes into the extraction solvent, thereby reducing the 
enrichment efficiency (Rezaee et al, 2010). The use of high density and toxic organic 
solvents (e.g., carbon tetrachloride, chloroform, dichloromethane) are other 
disadvantages of this technique (Leng et al., 2012).  
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Yiantzi et al. (2010) introduced another microextraction technique termed 
vortex-assisted liquid–liquid microextraction (VALLME) whereby dispersion of low 
density extraction solvent into water is obtained through vortex mixing (a mild 
emulsification procedure). The fine droplets could rapidly extract target analytes 
from water because of the shorter diffusion distance and larger interfacial area. After 
centrifugation, the floating extractant phase restores its initial single-drop shape. 
However, among the solvents (1-octanol, toluene, n-hexane, octane and cyclohexane) 
tested, only 1-octanol had the ability to restore its single-drop shape (Abu-Bakar et 
al., 2014). The rest of the tested solvents were left scattered on the surface of the 
aqueous samples and could not be effectively collected. 
 
Micro-solid phase extraction (μ-SPE) is another novel alternative 
microextraction technique for the pre concentration analytes in complex samples. 
Basically, this technique involves analyte adsorption followed by solvent desorption 
but on a much smaller scale where the sorbent was held within a membrane 
envelope. The key advantages of this technique are the minimized usage of solvent 
as well as the simple, inexpensive and high enrichment that can be achieved. It is 
also suitable for extractions in complex matrices as the sample clean-up and 
extraction steps are carried out simultaneously (Basheer et al., 2007). Table 1.5 
below shows the sample preparation technique and analytical method used for the 
EAAS analysis. 
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Table 1.6: Summary of sample preparation and analytical method for EAAS analysis.  
 
No Compound 
Type of 
Sample 
Sample 
Preparation 
Instrument References 
1 T, E, A, Etio Faeces LLE LC-MS 
Weltring et al., 
(2012) 
2 
Steroid 
Profile 
Urine 
SPE (Oasis 
HLB) 
UHPLC-
QTOF-
MS/MS 
Badoud et al., 
(2011) 
3 
Steroid 
Profile 
Urine 
SPE 
(Detectabuse
TM
) 
GC-MS 
Martinez-Brito et 
al., (2013) 
4 T Serum SPE (C18) LC-MS/MS 
Koren et al., 
(2012a) 
5 
Steroid 
Profile 
Urine LLE GC-MS/MS 
Van Eenoo et al., 
(2010) 
6 T Serum LLE LC-MS/MS Yang, (2011) 
7 T, E Urine SPME LC-MS/MS Zhan et al., (2011) 
8 T Tissue 
LLE, SPE 
(Oasis HLB) 
LC-MS/MS 
Surowiec et al., 
(2011) 
9 T, E, A, Etio Urine SPE (C18) GC-MS 
Ahmadkhaniha et 
al., (2010) 
10 T, E Saliva DLLME LC-MS/MS Sobhi et al., (2014) 
11 T, E Saliva SBSE GC-MS 
Stopforth et al., 
(2007) 
12 T Urine SPME-DMF LC-MS Choi et al., (2016) 
13 T Urine MIP LC-MS/MS Tse et al., (2010) 
15 
Anabolic 
steroids 
Urine LLE LC-MS/MS 
Deventer et al., 
(2006) 
16 
Anabolic 
steroids 
Urine LLE LC-MS/MS 
Mazzarino, et al., 
(2006) 
17 
Anabolic 
steroids 
Urine LLE LC-MS/MS 
Leinonen, et al 
(2002) 
 
1.5.1 MS in Doping Analysis 
 
In doping analysis, the detection of AAS in urine gained lots of attention 
with the introduction of mass spectrometric detection coupled to separating 
techniques like GC in the early eighties. Mass spectrometry was used for the first 
time in 1972 during the Munich Olympics. Since then various new chromatographic 
techniques such as HRMS (Atlanta Olympics Games 1996), isotope ratio mass 
spectrometry (IRMS) (Special Olympic Winter Games, 1998) and liquid 
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chromatography mass spectrometry (LC-MS) (Athens Olympic Games, 2004) have 
been utilised in dope testing. The WADA accredited labs around the world have their 
own set of testing protocols utilizing various equipments such as GC, GC-MS, 
HRMS, LC-MS/MS and IRMS (Mukesh, 2016). 
 
A suitable analytical method for AAS was developed by Donike et al. 
(1988). Analyses were performed on a bench-top quadrupole mass spectrometry 
(MS) coupled with capillary GC. AAS were cleaned up on a SPE XAD-2 column, 
followed by hydrolysis of conjugated metabolites using β-glucuronidase enzyme and 
LLE with diethyl ether under alkaline conditions. Prior to GC-MS analysis in 
selected ion monitoring mode (SIM), steroids were derivatized with a mixture of N-
methyl-N-(trimethylsilyl)trifluoroacetamide (MSTFA), trimethyliodosilane and an 
antioxidant to convert steroid hydroxyl and keto groups to their unique trimethylsilyl 
(TMS) ethers and enol ethers. Steroids excreted unconjugated in urine (free steroids) 
were analyzed separately by extracting urine samples directly or after SPE XAD-2 
clean-up with diethyl ether at basic pH, followed by selective derivatization resulting 
in the formation of O-TMS derivatives. In the case of stanozolol, the 
heptafluorobutyryl (HFB) -O-TMS derivative (Stolman and Pranitis, 1977) was used. 
Modifications from the original method include SPE C18 cartridges, LLE with 
tertbutyl methyl ether and combination of sample pretreatment and analysis of free 
and conjugated steroids (Achten et al., 2001). The variation includes direct 
hydrolysis of urine, followed by LLE and derivatization using D4AG and Etio for 
quality assurance (Adrian et al., 2011). A typical GC-MS in SIM mode takes 20-30 
min and incorporates 10-15 time-programmed acquisition groups of 15-20 ions. 
Limits of detection (LOD) between 2-30 ng mL
-1
 can be achieved (Asakawa et al., 
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1999). Negative and positive ion chemical ionization has been applied for HFB, 
pentafluoropropionyl, methoxy-TMS or TMS derivatives of many AAS metabolites 
but without significant enhancement in sensitivity (Jordi et al., 2000). Since 
sufficient LOD are not achieved for all steroids with the basic method, laboratories 
have been obliged to search complementary analytical methods to screen and 
confirm AAS (Reddy at al., 2009). 
 
In the early 1990s, LC-MS were commercialised with the first application in 
AAS in 1996. The application of modern and powerful analytical instruments 
consisting of LC, sophisticated atmospheric pressure ion sources, and sensitive mass 
analyzers has markedly improved the quality as well as speed of doping control 
analyses (Thevis and Schanzer, 2005). The technique of LC–MS/MS has 
complemented sports drug testing strategies ever since soft ionization interfaces such 
as electrospray or atmospheric pressure chemical ionization (ESI or APCI, 
respectively) became commercially available (Lanina et al., 2007). Numerous 
applications have been developed that allow the determination of prohibited 
therapeutics that is barely detectable or undetectable with conventional GC-MS 
instrument. Due to the progressive nature of doping controls, the continuously 
changing demands originating from the dynamic pharmaceutical market, new illegal 
approaches that presumably increase athletic performance and modifications to the 
lists of prohibited compounds of regulative authorities such as WADA, numerous 
new applications and drug-testing strategies based on LC-MS/MS were frequently 
developed. With the availability of LC interfaced to an MS by sophisticated 
ionization techniques such as ESI and APCI, doping control analysis has many 
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powerful options for specific, sensitive, fast, and robust procedures (Nicoli et al., 
2016). 
 
1.5.2 Isotope Ratio Mass Spectrometry in Doping Analysis 
 
Detection of doping with steroids that are structurally identical to those 
produced in the body (e.g. T, DHEA, DHT and 4-androstenedione) is a special case 
and a challenging task in sports drug testing, since their origin (endogenous or 
exogenous) is difficult to prove. Abuse of these steroids has been detected indirectly 
by measuring changes in absolute and relative concentrations of different 
endogenous steroids (steroid profile) in urine (Cawley and Flenker, 2008). The basic 
analysis successfully used for detection of T administration is based on the 
determination of the ratio to its 17α-epimer, E. At present, the cut-off level for T/E 
ratio is 4:1. Quantification can be carried out with the same GC-MS methods that are 
used for qualitative analysis of other AAS. All indirect tests rely on statistical 
population-based reference values and further individual investigations were often 
needed to exclude the possibility of an abnormal physiological or pathological 
condition. Doping with T and many other natural steroids can be confirmed directly 
by means of gas chromatography-combustion-carbon isotope ratio mass 
spectrometry (GC-C-IRMS) (Strahm et al., 2009).  
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Figure 1.2: Schematic depicting of a triple-collector IRMS system to analyze the 
isotopic composition of CO2. The same principle is used for analysis of the isotopes 
of 
16
O and 
1
H just with a different set-up of the collectors. (Adapted from SAHRA, 
2005)  
 
Isotope ratio mass spectrometry IRMS is a technique that gives precise and 
accurate measurements of the variation in the natural abundance of light stable 
isotopes (Sulzman, 2007). The mass spectrometric method is the most effective 
method for measuring isotope abundances, which is used to separate charged atoms 
according to their mass-to-charge ratio, denoted as m/z. IRMS instrument has two 
basic types which are the dual-inlet (DI-IRMS) and the continuous flow (CF-IRMS). 
Both of these types consist of the inlet system, ion source, mass analyzer and ion 
collection or detector. Figure 1.2 illustrates the difference between  DI-IRMS and 
CF-IRMS (Sulzman, 2007). 
 
Isotopes have the same number of protons and electrons but differing number 
of neutrons for an element (Sulzman, 2007). Isotopes are divided into two categories, 
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i.e., stable and unstable isotopes (Hoefs, 2009). Stable isotopes are those with stable 
energy and do not decay. Isotopes become stable when the neutrons and the protons 
become quite similar in numbers (Sulzman, 2007). Every element has a light isotope 
and one or two heavy isotopes. Examples of light isotopes are: carbon (
12
C), nitrogen 
(
14
N), oxygen (
16
O), hydrogen (
1
H) and sulfur (
32
S). Examples of the corresponding 
heavy isotopes are 
13
C, 
15
N, 
17
O, 
18
O, 
2
H, 
33
S and 
34
S (Benson et al., 2006). It is a fact 
that every biochemical process involves substances that contain one of these 
elements (C, N, H, O and S).  
 
The δ13C helped to distinguish between exogenous and endogenous steroids. 
It was found that, the ratio of T/E in urine can indicate synthetic steroids use 
(Ehleringer et al., 2007). The use of stable IRMS has shown that synthetic T has 
lower δ13C value than the endogenous hormone (Hernandez, 2008). The natural 
abundance isotope ratio data are generally reported  as delta values (δ ) which  are 
expressed in units per mil (mil=thousand) and written as ‰ (Benson et al., 2006). 
Delta value can be calculated and measured according to the following formula: 
 
δ  
    Sample     Standard     
  Standard
 1000 
R sample  is the ratio of the heavy to light isotope for the sample, while  R 
standard is the  same ratio for the standard (Benson et al., 2006).  
 
A positive value indicates that the sample has more heavy isotopes relative to 
the standard. Negative value indicates less of the heavy isotopes than the standard 
(Sulzman, 2007). There are many international standards that are used for isotope 
ratio measurement: Pee-Dee Belemnite (PDB), Atmospheric nitrogen (AIR), Vienna 
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standard mean ocean water (V-SMOW), Standard mean ocean chloride (SMOC) and 
the most important is Vienna-Pee-Dee Belemnite (V-PDB) (Benson et al., 2006). 
Stable isotope ratio is typically measured by a technique called isotope ratio mass 
spectrometry (IRMS). Table 1.6 shows the relative abundances of naturally occurring 
isotopes of the common elements which have been analyzed by IRMS (Benson et al., 
2006). 
Table 1.7: Relative abundances measurement for the isotopes of 
elements analyzed by IRMS (adapted from Benson et al., 2006) 
 
Element Isotope Relative abundance (%) 
Hydrogen (H) 
 
1
H 
2
H 
99.984 
0.0156 
Carbon (C) 
 
12
C 
13
C 
98.892 
1.108 
Nitrogen ( N) 
 
14
N 
15
N 
99.635 
0.365 
Oxygen ( O) 
16
O 
17
O 
18
O 
99.759 
0.037 
0.204 
Sulphur (S) 
 
32
S 
33
S 
34
S 
35
S 
95.020 
0.760 
4.220 
0.014 
 
GC-C-IRMS is a highly specialised instrumental used to ascertain the relative 
ratio of light stable isotopes of carbon (
13
C/
12
C), hydrogen (
2
H/
1
H), nitrogen 
(
15
N/
14
N) or oxygen (
18
O/
16
0) in individual compounds separated from often complex 
mixtures of components. The ratio of these isotopes in natural materials varies 
slightly as a result of isotopic fractionation during physical, chemical and biological 
processes resulting, in some cases, with the relative isotopic ratio of specific 
compounds being highly diagnostic of key processes (Augenstein, 1999). 
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 The technique of GC-C-IRMS is based on the compound specific isotope 
analysis (CSIA). Sano was the first who worked on GC-C-IRMS to measure carbon 
isotope ratios in 1976. From 1988, IRMS  started to be commercially available 
(Sulzman, 2007).  At the beginning only carbon was determined; then after some 
developments  for the system, it was able to conduct analysis of nitrogen, hydrogen 
and oxygen isotope ratios (Benson et al., 2006). Figure 1.3 shows the schematic 
diagram of the basic set up of GC-C-IRMS instrument for the analysis of carbon 
isotope ratios (Cawley and Flenker, 2008). The sample is injected onto the GC, 
where it will vaporize and pass through the column by following the helium carrier 
gas. The different components in the sample will be separated by their affinity with 
the stationary phase coated onto the inner wall of the column and the carrier gas. To 
avoid large amounts of solvent from entering the oxidation furnace, a backflush 
system using helium is used directly after the GC column. To allow the eluted 
compounds to enter the reactor, the backflush is turned off just before the expected 
retention time of the compounds of interest which is then submitted to the 
combustion oven, which consists of oxidation and reduction furnace.  To remove the 
water vapour which is generated during combustion, a water trap with an open split 
is required. All the carbon from each sample will be converted into CO2 by the 
oxidation furnace, which consists of an alumina ceramic capillary tube containing 
Cu, Ni and Pt wire. Cu will react with high purity O2 gas to form CuO at 650
°
C. Ni 
reacts with O2 to form NiO at 950
°
C in the presence of Pt as a catalyst for this 
reaction. In the reduction furnace, an excess of O2 is removed from the gas stream 
and nitrous oxides is reduced into N2-N2O. During the oxidation, H2O will be formed 
and removed by a Nafion membrane, a polymeric capillary which is permeable to 
water. When the H2O has been removed, the compounds enter the ConFlo IV, a gas 
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management device where the reference gas, CO2, can be added. Following this, the 
analyte gases pass  into  a stream of helium into the IRMS through an open split 
interface (Cawley and Flenker, 2008). 
 
In IRMS the gasses enter the ion source which is subsequently ionized by an 
emission of electrons under high vacuum, resulting in  positively charged ions 
(Benson et al., 2006). These are ionized by an emission of electrons under high 
vacuum, creating positively charged ions. These ions will be accelerated by an 
electric field toward a flight tube, where the separation is performed according to the 
mass-to-charge ratio. These ions are accelerated to 3 kV energy and then separated 
according to the mass-to-charge ratio m/z. These ions are collected in an ion detector 
called Faraday cups (Benson et al., 2006). Faraday cups are long and narrow tubes 
made of metal, which prevent the ions and secondary electrons from getting out 
(Sulzman, 2007); this consists of three cups positioned to collect the ions of m/z 44, 
45 and 46. The ion currents are sent to the data system to be reported. As an example 
for the analysis of CO2, the data consists of three traces for the different isotopes and 
its corresponding masses are m/z 44, 45 and 46. These masses represent 
12
C
16
O
16
O, 
13
C
16
O
16
O and 
12
C
16
O
18
O respectively (Cawley and Flenker, 2008).  
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Figure 1.3: Schematic diagram of a typical GC-C-IRMS (adapted from Cawley and 
Flenker, 2008) 
  
The differentiation of endogenous and exogenous steroids is important in doping 
analysis. The approach is based on the fact that chemically manufactured and 
endogenously produced steroids have small differences in their carbon isotope 
(
13
C/
12
C) ratio. Chemically manufactured steroids are synthesized from certain plant 
sterols that have low 
13
C content, while the 
13
C content of human body is higher and 
reflects the diet. In the assay, the 
13
C/
12
C ratio is determined from possibly 
administered steroids or their metabolites (e.g. A, Etio, 5αAdiol and 5βAdiol) and 
compared with the 
13
C/
12
C ratio of other endogenous steroids that are not affected by 
the administrated steroid (e.g. pregnandiol (PD), 11-ketoetiocholanolone 
(11KetoEtio)). The results will be reported as consistent with steroid administration 
provided that the 
13
C/
12
C value measured for the metabolite differs by three or more 
delta units depending on the endogenous reference compound (ERC) (WADA 
TD2016IRMS). 
 
 
 
